Season of birth in amyotrophic lateral sclerosis

V Ajdacic-Gross1, J Wang, F Gutzwiller

  • 1Institute of Social and Preventive Medicine, Zurich, Switzerland.

Insights

Amyotrophic Lateral Sclerosis (ALS) risk may be linked to birth season. This study found more ALS cases were born in spring, suggesting early-life factors influence the disease over a long period.

Area of Science:

  • Neurology
  • Epidemiology
  • Public Health

Background:

  • Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease.
  • Understanding the etiology of ALS is crucial for developing effective interventions.
  • Birth cohort effects and environmental factors are increasingly recognized as potential contributors to ALS.

Purpose of the Study:

  • To investigate the association between season of birth and the risk of developing Amyotrophic Lateral Sclerosis (ALS).
  • To explore potential early-life risk factors for ALS.
  • To examine the relationship between birth timing and ALS onset.

Main Methods:

  • Analysis of computerized death records from Swiss mortality statistics covering the period 1969-1993.
  • Statistical examination of birth dates for individuals diagnosed with ALS.
  • Comparison of birth season distributions between ALS patients and the general population.

Main Results:

  • A statistically significant excess of births was observed during the spring months (March, April, May) among individuals with ALS.
  • The findings suggest a potential seasonal pattern in ALS incidence.
  • This seasonal association points towards environmental exposures or factors acting early in life.

Conclusions:

  • The season of birth may be a relevant factor in Amyotrophic Lateral Sclerosis (ALS) etiology.
  • Risk factors for ALS could be acquired during prenatal or early postnatal periods.
  • The long latency between early-life exposures and ALS onset is a critical consideration for future research.

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...